Perioperative hyperamylasemia in cyclosporine-treated renal transplant recipients: does it have clinical significance?
Ihara
H
H
Department of Urology, Hyogo College of Medicine, Japan.
Ogino
T
T
Hosokawa
S
S
Yabumoto
H
H
Arima
M
M
Ikoma
F
F
D000293:Adolescent; D000328:Adult; D000681:Amylases / Q000097:blood*; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007527:Isoenzymes / Q000097:blood*; D016030:Kidney Transplantation; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012263:Ribonucleosides / Q000627:therapeutic use; D014184:Transplantation, Homologous
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D007527:Isoenzymes; D012263:Ribonucleosides; C010052:mizoribine; D000681:Amylases; D001379:Azathioprine; D008775:Methylprednisolone